Cigna Group 10-Q

Item 5. OTHER INFORMATION Rule 10b5-1 Plan Elections During the three months ended March 31, 2026, the following 10b5-1 director and officer trading plan arrangement change occurred: 1. On February 6, 2026 , David Cordani , Chair and Chief Executive Officer of The Cigna Group , adopted a 10b5-1 plan. Mr. Cordani's plan provides for (i) the sale of shares of The Cigna Group common stock issuable upon vesting of performance awards (the actual number of shares depends on actual performance achieved and may range from 0% to 200% of the 62,366 shares subject to the awards at the target level of performance), net of shares withheld to satisfy applicable tax obligations; and (ii) the exercise of up to 212,543 vested stock options and the associated sale of shares of The Cigna Group common stock acquired upon exercise to cover the exercise price, applicable tax obligations and fees and 50% of the resulting net shares acquired upon exercise (such limitation reflecting The Cigna Group stock ownership guidelines), through April 30, 2027 . This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934 and the Company's policies regarding insider transactions. 41 Item 6. EXHIBITS INDEX TO EXHIBITS Number Description Method of Filing 3.1 Restated Certificate of Incorporation of The Cigna Group Filed by the registrant as Exhibit 3.1 to the Quarterly Report on Form 10-Q for the period ended June 30, 2023 and incorporated herein by reference. 3.2 Amended and Restated By-laws of The Cigna Group Filed by the registrant as Exhibit 3.3 to the Current Report on Form 8-K on February 13, 2023 and incorporated herein by reference. 10.1* Offer Letter for David Cordani dated February 25, 2026 Filed herewith. 10.2* Offer Letter for Brian Evanko dated February 25, 2026 Filed herewith. 10.3* Form of The Cigna Group Long-Term Incentive Plan (the “Cigna LTIP”): Nonqualified Stock Option Grant Agreement Filed herewith. 10.4* Form of Cigna LTIP: Strategic Performance Share Grant Agreement Filed herewith. 10.5* Form of Cigna LTIP: Restricted Stock Grant Agreement Filed herewith. 10.6* Form of Cigna LTIP: Covenant Agreement Filed herewith. 10.7* Form of Cigna LTIP: Strategic Performance Share Grant Agreement for David Cordani Filed herewith. 31.1 Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 Filed herewith. 31.2 Certification of Chief Financial Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 Filed herewith. 32.1 Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 Furnished herewith. 32.2 Certification of Chief Financial Officer of The Cigna Group pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 Furnished herewith. 101 The following materials from The Cigna Group Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Consolidated Statements of Income; (ii) the Consolidated Statements of Comprehensive Income; (iii) the Consolidated Balance Sheets; (iv) the Consolidated Statements of Total Equity; (v) the Consolidated Statements of Cash Flows; and (vi) the Notes to the Consolidated Financial Statements Filed herewith. 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) Filed herewith. * Indicates a management contract or compensatory plan or arrangement. 42 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: April 30, 2026 THE CIGNA GROUP /s/ Ann M. Dennison Ann M. Dennison Executive Vice President and Chief Financial Officer (Principal Financial Officer and Authorized Signatory) 43